Combination therapy

Details for Australian Patent Application No. 2007281677 (hide)

Owner Genzyme Corporation

Inventors Pelus, Louis M.; Bridger, Gary

Agent Davies Collison Cave

Pub. Number AU-A-2007281677

PCT Pub. Number WO2008/019371

Priority 60/836,409 07.08.06 US

Filing date 7 August 2007

Wipo publication date 14 February 2008

International Classifications

A61K 38/02 (2006.01) Medicinal preparations containing peptides - Peptides of undefined number of amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (1970.01) Medicinal preparations containing peptides - Cytokines

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/019371 Priority application(s): WO2008/019371

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007281678-2-aminobenzoxazole carboxamides as 5HT3 modulators

2007281648-Methods of making calibrated analyte sensors